Depomed hires Kyalin chief executive
July 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Depomed, Srinivas Rao
California-based speciality pharma firm Depomed has appointed Dr Srinivas Rao as its chief medical officer (CMO) and senior VP. Rao …
AbbVie agrees to buy Shire for £32bn
July 18, 2014Sales and Marketing AbbVie, Abbott, Humira, Shire, merger, new abbvie, takeover
Shire has accepted a £32 billion takeover deal from AbbVie after months of rejections and uncertainty. The firm, which is …
GSK melanoma drugs beat rival in new study
July 18, 2014Sales and Marketing GSK, Roche, Tafinlar, Yervoy, Zelboraf, mekinist, melanoma
GlaxoSmithKline’s new combination melanoma treatment has bested Roche’s established oncology drug Zelboraf when treating patients with the deadliest form of …
Mixed bag for Genentech dementia drug
July 18, 2014Research and Development, Sales and Marketing Alzheimer's, Genentech, crenezumab, dementia
A Phase II clinical trial for Genentech’s investigational Alzheimer’s drug failed to meet its primary endpoints – but the company …
Pfizer to pay $360m for InnoPharma
July 18, 2014Sales and Marketing Pfizer, injectables, innopharma
Pfizer is to pay as much as $360 million for private pharma development company InnoPharma in a financial arrangement comprising …
New chairman for Leukemia & Lymphoma Society
July 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Leukemia & Lymphoma. jim davis
James Davis has been elected chairman of the national board of directors of The Leukemia & Lymphoma Society (LLS). Davis …
New drugs see J&J sales rise
July 17, 2014Medical Communications, Sales and Marketing J&J, JJ, Q2, hepatitis C, olysio, sovaldi
Johnson & Johnson saw sales rise 9.1% to $19.5 billion year on year on the back of a strong performance …
Bayer hires litigation head from Pfizer
July 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Malini Moorthy, Pfizer
Bayer Healthcare has appointed Malini Moorthy to head up its litigation department in the US. Moorthy joins the German firm from …
Lilly signs Immunocore deal
July 17, 2014Research and Development, Sales and Marketing Cancer, Oxford, biotech, immunocore, lilly
Eli Lilly has signed a deal with one of the UK’s most high-profile biotech firms to research and potentially develop …
Deallus Consulting sees new chief executive
July 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Claudio D’Ambrosio, consulting, deallus
Life sciences consultancy firm Deallus Consulting has confirmed its new chief executive is to be Dr Claudio D’Ambrosio. D’Ambrosio succeeds …
Migrants must pay more for treatment on NHS
July 16, 2014Medical Communications, Sales and Marketing NHS, health tourism, migrants
Non-EU citizens will soon have to pay 150% of the cost of treatment on the NHS under new plans announced …
FDA speedy review for new Avastin licence
July 16, 2014Research and Development, Sales and Marketing Cancer, Roche, avastin, cervical cancer
The FDA has granted priority review status for Roche’s Avastin (bevacizumab) plus chemotherapy in women with persistent, recurrent or metastatic …
Hikma completes Bedford Laboratories purchase
July 16, 2014Manufacturing and Production Ben Venue, Boehringer, Hikma, bedford laboratories
Hikma has completed its acquisition of assets of the US generic injectables business Bedford Laboratories from Ben Venue Laboratories, a …
Chiltern acquires Ockham to help lift status
July 16, 2014Manufacturing and Production CRO, chiltern, contract research, fsp, ockham
Chiltern has today acquired a full stake in fellow contract research organisation Ockham as both companies look to merge their …
Novartis makes Alzheimer’s deal
July 16, 2014Research and Development, Sales and Marketing Alzheimer's, Genentech, Novartis, bai, epstein
Novartis is to collaborate with the Banner Alzheimer’s Institute (BAI) to test two of the Swiss company’s investigational anti-amyloid treatments. …
Merck Serono appoints R&D global head
July 16, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Luciano Rossetti, Merck Serono
Merck Serono the biopharma of division of US firm Merck has confirmed the appointment of Luciano Rossetti as its executive …
Novartis forms alliance with Google on ‘smart lens’
July 15, 2014Medical Communications, Sales and Marketing Alcon, Novartis, diabetes, e-health, google, smart lens, wearable
Novartis eye care division Alcon has struck a deal with Google to develop a ‘smart’ contact lens designed to help …
Illumina ‘gets 100,000 Genomes contract’
July 15, 2014Manufacturing and Production, Sales and Marketing Cambridge, DNA, DoH, NHS, genomes, illimina
Gene analysis specialist Illumina has been chosen to deliver a project to sequence 100,000 whole genomes from NHS patients by …
UK science minister steps down
July 15, 2014Medical Communications, Sales and Marketing Cameron, UK, Willetts, cabinet, parliament, science minister
The science and universities minister David Willetts has resigned as British prime minister David Cameron carries out a major cabinet …
Targacept admits failure in Alzheimer’s trial
July 15, 2014Research and Development, Sales and Marketing Alzheimer's, Aricept, Pfizer, TC-173, Targacept
Targacept is dropping a once promising Alzheimer’s drug from further clinical trials after it failed to beat Pfizer’s Aricept (donepezil) …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
